Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Salaries and benefits

Supplies

Other operating expenses

Equity in earnings of affiliates

Depreciation and amortization

Interest expense

Gains on sales of facilities

Losses on retirement of debt

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

HCA Healthcare

HCA Healthcare, Inc. is a health care services company engaged in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities. The firm operates general and acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services, and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was founded by Dr. Thomas F. Frist, Jr in 1968 and is headquartered in Nashville, TN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

HCA Healthcare reports robust Q4 performance and outlines strategic growth

HCA Healthcare's Q4 2022 performance reflects strong same-facility volumes, stable labor costs, and strategic investments in growth areas.
The company's focus on overcoming challenges, leveraging strengths, and seizing opportunities positions them for sustainable growth and operational excellence.
With a clear agenda for 2023, including revenue guidance and investment plans, HCA Healthcare aims to navigate market dynamics and drive value creation.
By addressing key performance metrics, managing costs effectively, and pursuing strategic initiatives, HCA Healthcare demonstrates a commitment to long-term success.

HCA Healthcare reports robust Q1 earnings amidst operational enhancements

HCA Healthcare delivered strong financial performance with notable growth in key metrics and operational efficiency improvements.
While facing challenges from COVID-related impacts and procedural shifts, the company is focused on maintaining positive volume trends and managing costs effectively.
Opportunities lie in investing in capabilities, capacity improvement, and navigating contract renewals in an inflationary environment.

HCA Healthcare reports robust Q2 earnings amidst strategic investments

HCA Healthcare's Q2 2023 performance reflects strong earnings, revenue growth, and cash flow, supported by strategic investments.
While facing challenges like margin impact from acquisitions and rising capital spending, the company is well-positioned for growth.
Opportunities lie in optimizing labor costs, expanding services, and leveraging positive payer mix trends for sustained success.
Overall, HCA's focus on quality care, financial prudence, and growth initiatives underpins a positive outlook for the future.

HCA Healthcare manages challenges, eyes sustained growth amid revenue optimizations

HCA Healthcare navigated challenges from the Valesco venture to deliver solid financial performance. The company's focus on quality care, cost management, and revenue optimization positions it for sustained growth. Anticipation of improved margins, strategic growth discussions, and operational enhancements highlight a positive outlook for the future.

HCA Healthcare reports robust Q4 earnings and outlines growth strategies

HCA Healthcare's strong Q4 performance and strategic investments position it well for growth in 2024, with a focus on cost management and operational efficiency.
The company's confidence in navigating industry challenges, coupled with initiatives to drive value and improve patient outcomes, underpin its optimistic outlook for the future.
With a clear focus on growth drivers like Medicare Advantage admissions and revenue per equivalent admission, HCA Healthcare is poised for a promising year ahead.

HCA Healthcare posts robust Q1 earnings, eyes sustained growth opportunities

HCA Healthcare's Q1 2024 performance reflects strong financial results and operational efficiency, supported by favorable same-facility volumes and effective cost management. While facing challenges in outpatient cases, the company is well-positioned to capitalize on opportunities for growth.
Strategic investments in infrastructure, technology, and campus integration are strengthening HCA Healthcare's operational capabilities and market positioning. Monitoring Medicaid statuses and potential procedure rebounds are key focus areas for the company.

HCA Healthcare reports robust Q2 earnings amidst market challenges

HCA Healthcare's Q2 2024 performance reflects strong financial growth, driven by increased revenues and improved margins.
While challenges like managing capital expenditures persist, opportunities in payer mix optimization and market demand offer avenues for further growth.
The company's ability to navigate evolving market dynamics and capitalize on strategic opportunities will be key to sustaining its positive momentum.

HCA Healthcare reports resilient Q3 results amid hurricane challenges

HCA Healthcare's Q3 performance showcased resilience amidst hurricane challenges, with strong volume and revenue growth.
Investments in network expansion and technology underscore the company's commitment to quality care and operational efficiency.
While challenges from hurricanes persist, HCA Healthcare sees opportunities for earnings growth and value creation in the near future.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA), one of the nation's leading healthcare providers, today announced it will host its sixth annual “Crush the Crisis” national prescription drug take back day on Saturday, Oct. 26, 2024. This year, 133 HCA Healthcare facilities across the country will partner with local law enforcement to help communities safely and anonymously dispose of unused or expired medications. Held each year, in alignment with the Drug Enforcement Admini.

HCA Healthcare to Host Sixth Annual “Crush the Crisis” National Prescription Drug Take Back Day

I previously rated HCA Healthcare a hold due to flat DCF price target of $319 and mixed industry trends. Since my last analysis, industry cost pressures have eased while healthcare spending continues to grow. With additional upside potential and risks mitigated, I raise my rating to buy at a price target of $447.

HCA Healthcare Q3 Earnings Preview: Step Change In Value (Rating Upgrade)

Vertex Pharmaceuticals

There's no need to change a winning formula.

Prediction: These 2 Stocks Will Beat the S&P 500 Through 2030

HCA (HCA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

HCA Healthcare (HCA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

NASHVILLE--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA), is scheduled to present at the following healthcare conferences: November 14, 2024 at 7:15am PT at the 2024 UBS Global Healthcare Conference at the Terranea Resort in Ranchos Palos Verdes, CA. November 20, 2024 at 11:20am ET at the 2024 Wolfe Research Healthcare Conference at the Wolfe Offices in New York, NY. November 21, 2024 at 8:00am CT at the 2024 Stephens Annual Investment Conference at the Grand Hyatt in Nashville, TN. A link.

HCA Healthcare, Inc. to Present at November Healthcare Conferences

Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "General Medical and Surgical Hospitals Market (2024 Edition): Analysis by Service Type, Hospital Type, Service Area, and Region: Market Insights and Forecast (2020-2030)" report has been added to ResearchAndMarkets.com's offering. This report provides a complete analysis of the Global General Medical and Surgical Hospitals industry for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030. The Global General Medical and Surgical Hospitals market showcased growth at a CAGR of 5.19% during 2020-2023. The market was valued at USD 3.33 trillion in 2023 which is expected to reach USD 4.99 trillion in 2030.

General Medical and Surgical Hospitals Industry Report, 2024: Analysis by Service Type, Hospital Type, and Service Area (2020-2030) Featuring Profiles of Key Players - HCA Healthcare, Apollo Hospitals & More

HCA (HCA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Will HCA (HCA) Beat Estimates Again in Its Next Earnings Report?

Apple

Accenture Plc

Allegion

Applied Materials

Amphenol

Cintas Corp

D.R. Horton

Dick's Sporting Goods

Domino's Pizza

EOG Resources

Fastenal

FactSet Research Systems

Graco

Garmin

W.W. Grainger

Home Depot

Hershey

Jack Henry & Associates

KLA-Tencor

Lincoln Electric Hlds

Eli Lilly

Lam Research

Mastercard

MarketAxess Holdings

I track 50 high-quality dividend stocks, updating their valuations daily to identify Strong Buy, Buy, Hold, and Trim opportunities based on historical free cash flow trends. September's performance: Strong Buy portfolio gained 4.75%, Buy or better 3.18%, and Expected ROR 2.01%, all outperforming the investable universe and SCHD. My hypothesis is these model portfolios will deliver alpha over SPY and SCHD long term, focusing on attractively valued stocks and expected returns.

Top 50 High Quality Dividend Stocks - September 2024 Results

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA), one of the nation's leading healthcare providers, today announced that it will contribute $1 million through community organizations to aid in Hurricane Helene relief efforts in North Carolina. On Thursday, September 26, Hurricane Helene made landfall as a powerful category 4 hurricane, leaving more than four million people without power and causing major damage as it traveled throughout the Southeast. When the storm hit Ashev.

HCA Healthcare to Donate $1 Million Towards Hurricane Helene Disaster Relief Efforts in North Carolina

HCA Healthcare has consistently outperformed the S&P 500, with shares up 43.8% since April 2023 and 66.8% since August 2021. Despite a decline in net income due to asset sales and rising interest expenses, other profitability metrics like operating cash flow and EBITDA have improved. Management's guidance for 2024 anticipates significant revenue and net income growth, with expected revenue between $69.75 billion and $71.75 billion.

HCA Healthcare: Still A Great Play On Long-Term Growth And Valuation

Tenet Healthcare

Universal Health Services

The U.S. hospital industry has been flying high in the past year. Three hospital stocks to buy are: HCA, THC, UHS.

3 Hospital Stocks to Buy With Strong Earnings Estimate Revisions

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast: What: HCA Healthcare, Inc. 3Q Earnings Release Call When: Friday, October 25, 2024 at 9:00 am central (10:00 am eastern) How: Live Audio over the Internet:   https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, frank.morgan@hcahealthcare.com If you are unable to listen during the live webcast, the call w.

HCA Healthcare, Inc. 3rd Quarter 2024 Earnings Conference Call

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today presented its annual HCA Healthcare Awards of Distinction at a ceremony in Nashville, Tennessee. The HCA Healthcare Awards of Distinction, which include the Frist Humanitarian Award, the HCA Healthcare Innovators Award and the HCA Healthcare Excellence in Nursing Award, are the highest honors HCA Healthcare bestows on employees, physicians and volunteers, recognizing the e.

HCA Healthcare Presents 2024 Awards of Distinction

Cabot

CRA International

Leidos Hld

NetApp

NetApp, Cabot, Leidos Holdings, Charles River and HCA Healthcare could be compelling picks amid a low rate scenario.

5 Dividend Growth Stocks Likely to Outperform Amid Low Rates

Fortinet

PayPal

As the stock market reaches new record highs, investors are searching for the next set of winners to ride the wave of momentum into the next bull run. With a combination of strong fundamentals, top Zacks Ranks, and solid growth potential, a few stocks stand out from the crowd.

Stocks Make Record Highs: 3 Top Buys for the Next Bull Run

HCA (HCA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

HCA (HCA) Upgraded to Strong Buy: Here's What You Should Know

HCA Healthcare (HCA) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

How HCA Healthcare (HCA) Stock Stands Out in a Strong Industry

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.

HCA Healthcare (HCA) Boasts Earnings & Price Momentum: Should You Buy?

Cool Co Ltd

CSG Systems International

360 Finance Inc - ADR

Sterling Construction

QFIN, CLCO, HCA, STRL and CSGS have been added to the Zacks Rank #1 (Strong Buy) List on September 20, 2024.

New Strong Buy Stocks for September 20th

HCA benefits from expanding insurance coverage, rising demand and improving margins.

HCA Healthcare Stock Up 18.4% in 3 Months: Can You Afford to Miss Out?

Hubbell

Ferrari

Vertex, Inc.

Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. HCA, HUBB, RACE and VERX are some stocks that hold promise.

4 GARP Stocks to Scoop up for Maximum Returns

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

HCA Healthcare (HCA) is a Top-Ranked Momentum Stock: Should You Buy?

Affirm

Canadian Imperial Bank of Commerce

LSI Industries

Southside Bancshares

AFRM, SBSI, LYTS, CM and HCA have been added to the Zacks Rank #1 (Strong Buy) List on September 12, 2024.

New Strong Buy Stocks for September 12th

EMCOR Group

Invesco Dynamic Building & Construction ETF

Health Care Select Sector SPDR Fund

The U.S. economy added 142, 000 jobs in August 2024, more than a downwardly revised 89, 000 in July but below forecasts of 160, 000.

2 Sector ETFs & Stocks to Bet on Following August Jobs Data

Here is how HCA Healthcare (HCA) and Arbutus Biopharma (ABUS) have performed compared to their sector so far this year.

Are Medical Stocks Lagging HCA Healthcare (HCA) This Year?

News for HCA Healthcare Stock (HCA)